Index
1 Pneumococcal Vaccine Market Overview
1.1 Product Overview and Scope of Pneumococcal Vaccine
1.2 Pneumococcal Vaccine Segment by Type
1.2.1 Global Pneumococcal Vaccine Market Value Comparison by Type (2024-2030)
1.2.2 PPSV 23
1.2.3 PCV 7/13
1.2.4 PCV 10
1.3 Pneumococcal Vaccine Segment by End User
1.3.1 Global Pneumococcal Vaccine Market Value by End User: (2024-2030)
1.3.2 Child
1.3.3 Adult
1.4 Global Pneumococcal Vaccine Market Size Estimates and Forecasts
1.4.1 Global Pneumococcal Vaccine Revenue 2019-2030
1.4.2 Global Pneumococcal Vaccine Sales 2019-2030
1.4.3 Global Pneumococcal Vaccine Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Pneumococcal Vaccine Market Competition by Manufacturers
2.1 Global Pneumococcal Vaccine Sales Market Share by Manufacturers (2019-2024)
2.2 Global Pneumococcal Vaccine Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Pneumococcal Vaccine Average Price by Manufacturers (2019-2024)
2.4 Global Pneumococcal Vaccine Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Pneumococcal Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Pneumococcal Vaccine, Product Type & Application
2.7 Pneumococcal Vaccine Market Competitive Situation and Trends
2.7.1 Pneumococcal Vaccine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Pneumococcal Vaccine Players Market Share by Revenue
2.7.3 Global Pneumococcal Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Pneumococcal Vaccine Retrospective Market Scenario by Region
3.1 Global Pneumococcal Vaccine Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Pneumococcal Vaccine Global Pneumococcal Vaccine Sales by Region: 2019-2030
3.2.1 Global Pneumococcal Vaccine Sales by Region: 2019-2024
3.2.2 Global Pneumococcal Vaccine Sales by Region: 2025-2030
3.3 Global Pneumococcal Vaccine Global Pneumococcal Vaccine Revenue by Region: 2019-2030
3.3.1 Global Pneumococcal Vaccine Revenue by Region: 2019-2024
3.3.2 Global Pneumococcal Vaccine Revenue by Region: 2025-2030
3.4 North America Pneumococcal Vaccine Market Facts & Figures by Country
3.4.1 North America Pneumococcal Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Pneumococcal Vaccine Sales by Country (2019-2030)
3.4.3 North America Pneumococcal Vaccine Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Pneumococcal Vaccine Market Facts & Figures by Country
3.5.1 Europe Pneumococcal Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Pneumococcal Vaccine Sales by Country (2019-2030)
3.5.3 Europe Pneumococcal Vaccine Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Pneumococcal Vaccine Market Facts & Figures by Country
3.6.1 Asia Pacific Pneumococcal Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Pneumococcal Vaccine Sales by Country (2019-2030)
3.6.3 Asia Pacific Pneumococcal Vaccine Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Pneumococcal Vaccine Market Facts & Figures by Country
3.7.1 Latin America Pneumococcal Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Pneumococcal Vaccine Sales by Country (2019-2030)
3.7.3 Latin America Pneumococcal Vaccine Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Pneumococcal Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Pneumococcal Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Pneumococcal Vaccine Sales by Country (2019-2030)
3.8.3 Middle East and Africa Pneumococcal Vaccine Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Pneumococcal Vaccine Sales by Type (2019-2030)
4.1.1 Global Pneumococcal Vaccine Sales by Type (2019-2024)
4.1.2 Global Pneumococcal Vaccine Sales by Type (2025-2030)
4.1.3 Global Pneumococcal Vaccine Sales Market Share by Type (2019-2030)
4.2 Global Pneumococcal Vaccine Revenue by Type (2019-2030)
4.2.1 Global Pneumococcal Vaccine Revenue by Type (2019-2024)
4.2.2 Global Pneumococcal Vaccine Revenue by Type (2025-2030)
4.2.3 Global Pneumococcal Vaccine Revenue Market Share by Type (2019-2030)
4.3 Global Pneumococcal Vaccine Price by Type (2019-2030)
5 Segment by End User
5.1 Global Pneumococcal Vaccine Sales by End User (2019-2030)
5.1.1 Global Pneumococcal Vaccine Sales by End User (2019-2024)
5.1.2 Global Pneumococcal Vaccine Sales by End User (2025-2030)
5.1.3 Global Pneumococcal Vaccine Sales Market Share by End User (2019-2030)
5.2 Global Pneumococcal Vaccine Revenue by End User (2019-2030)
5.2.1 Global Pneumococcal Vaccine Revenue by End User (2019-2024)
5.2.2 Global Pneumococcal Vaccine Revenue by End User (2025-2030)
5.2.3 Global Pneumococcal Vaccine Revenue Market Share by End User (2019-2030)
5.3 Global Pneumococcal Vaccine Price by End User (2019-2030)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Corporation Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Pneumococcal Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Pfizer Pneumococcal Vaccine Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 GSK
6.2.1 GSK Corporation Information
6.2.2 GSK Description and Business Overview
6.2.3 GSK Pneumococcal Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.2.4 GSK Pneumococcal Vaccine Product Portfolio
6.2.5 GSK Recent Developments/Updates
6.3 MSD
6.3.1 MSD Corporation Information
6.3.2 MSD Description and Business Overview
6.3.3 MSD Pneumococcal Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.3.4 MSD Pneumococcal Vaccine Product Portfolio
6.3.5 MSD Recent Developments/Updates
6.4 Sanofipasteur
6.4.1 Sanofipasteur Corporation Information
6.4.2 Sanofipasteur Description and Business Overview
6.4.3 Sanofipasteur Pneumococcal Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Sanofipasteur Pneumococcal Vaccine Product Portfolio
6.4.5 Sanofipasteur Recent Developments/Updates
6.5 CDIBP
6.5.1 CDIBP Corporation Information
6.5.2 CDIBP Description and Business Overview
6.5.3 CDIBP Pneumococcal Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.5.4 CDIBP Pneumococcal Vaccine Product Portfolio
6.5.5 CDIBP Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Pneumococcal Vaccine Industry Chain Analysis
7.2 Pneumococcal Vaccine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Pneumococcal Vaccine Production Mode & Process
7.4 Pneumococcal Vaccine Sales and Marketing
7.4.1 Pneumococcal Vaccine Sales Channels
7.4.2 Pneumococcal Vaccine Distributors
7.5 Pneumococcal Vaccine Customers
8 Pneumococcal Vaccine Market Dynamics
8.1 Pneumococcal Vaccine Industry Trends
8.2 Pneumococcal Vaccine Market Drivers
8.3 Pneumococcal Vaccine Market Challenges
8.4 Pneumococcal Vaccine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer